Peptides as key components in the design of non-viral vectors for gene delivery

被引:6
|
作者
Thomas, Joseph [1 ]
Punia, Kamia [1 ]
Montclare, Jin Kim [1 ,2 ,3 ,4 ]
机构
[1] New York Univ Tandon, Dept Chem & Biomol Engn, Sch Engn, Brooklyn, NY USA
[2] Suny Downstate Med Ctr, Dept Biochem, Brooklyn, NY 11203 USA
[3] NYU, Dept Chem, New York, NY USA
[4] NYU, Coll Dent, Dept Biomat, New York, NY USA
基金
美国国家卫生研究院;
关键词
biomaterials; gene delivery; peptide; polypeptide; nucleic acid; CELL-PENETRATING PEPTIDES; IN-VIVO; PROTEIN TRANSDUCTION; TAT-PEPTIDE; ENDOTHELIAL-CELLS; ENDOSOMAL ESCAPE; SIRNA DELIVERY; GROWTH-FACTOR; PLASMID DNA; CANCER;
D O I
10.1002/pep2.24189
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Successful clinical implementation of gene delivery relies on the use of viral or non-viral based vectors to package and protect the therapeutic nucleic acid. These vehicles must also be able to direct the fate of the cargo once it has entered the cell to ensure that the nucleic acid is functional, and the desired outcome is achieved. Compared to viral vectors, non-viral vectors have the advantage of incorporating different material types such as lipids, polymers, and peptides to tune overall safety and efficacy. Peptides are especially powerful when used in gene delivery vectors as they are able to increase gene delivery efficacy by introducing new biochemical functionality. This review will discuss the use of peptides as central design components in non-viral gene delivery vectors. The contribution of the peptide component to the overall functionality of the delivery vehicle will be highlighted, with a focus on peptides as the only vehicle component or peptides in complex assemblies with lipids or polymers.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Synthetic peptides as non-viral DNA vectors
    Fabre, John W.
    Collins, Louise
    CURRENT GENE THERAPY, 2006, 6 (04) : 459 - 480
  • [22] Non-viral gene delivery
    Behr, JP
    EUROCANCER 98, 1998, : 255 - 256
  • [23] Editorial: Non-viral vectors for gene therapy/nucleic acid delivery
    Poddar, Arpita
    Banerjee, Rajkumar
    Shukla, Ravi
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2023, 11
  • [24] DENDRITIC ARCHITECTURES AS NON-VIRAL GENE DELIVERY VECTORS: CHALLENGES AND PERSPECTIVES
    Rusu, Radu Dan
    Clima, Lilia
    Pinteala, Mariana
    REVUE ROUMAINE DE CHIMIE, 2018, 63 (7-8) : 581 - 592
  • [25] Evaluation of multicomponent non-viral vectors for liver directed gene delivery
    Wu, CH
    Sapozhnikov, E
    Wu, GY
    JOURNAL OF DRUG TARGETING, 2002, 10 (02) : 105 - 111
  • [26] Strategies for cancer gene-delivery improvement by non-viral vectors
    Santana-Armas, Maria L.
    de Ilarduya, C. Tros
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 596
  • [27] In vivo gene delivery mediated by non-viral vectors for cancer therapy
    Mohammadinejad, Reza
    Dehshahri, Ali
    Madamsetty, Vijay Sagar
    Zahmatkeshan, Masoumeh
    Tavakol, Shima
    Makvandi, Pooyan
    Khorsandi, Danial
    Pardakhty, Abbas
    Ashrafizadeh, Milad
    Afshar, Elham Ghasemipour
    Zarrabi, Ali
    JOURNAL OF CONTROLLED RELEASE, 2020, 325 : 249 - 275
  • [28] Amphiphilic cationic cyclodextrins as non-viral vectors for gene and siRNA delivery
    O'Neill, Martin
    Guo, Jianfeng
    Fisher, Karen
    Walsh, Melanie
    Byrne, Colin
    Darcy, Raphael
    O'Driscoll, Caitriona
    HUMAN GENE THERAPY, 2007, 18 (10) : 1052 - 1053
  • [29] Enhancing intracranial delivery of clinically relevant non-viral gene vectors
    Berry, Sneha
    Mastorakos, Panagiotis
    Zhang, Clark
    Song, Eric
    Patel, Himat
    Suk, Jung Soo
    Hanes, Justin
    RSC ADVANCES, 2016, 6 (48): : 41665 - 41674
  • [30] Influence of physicochemical properties on pharmacokinetics of non-viral vectors for gene delivery
    Takakura, Y
    Nishikawa, M
    Yamashita, F
    Hashida, M
    JOURNAL OF DRUG TARGETING, 2002, 10 (02) : 99 - 104